BioSpace News Archive

Babson Diagnostics (Babson), a transformative diagnostic blood testing company, announced today that its SARS-CoV-2 IgG antibody test, Babson Diagnostics aC19G1, has received emergency use authorization (EUA) from the Food and Drug Administration (FDA). Babson Diagnostics aC19G1 is a COVID-19 serology test that enables the qualitative detection of IgG antibodies to SARS-CoV-2 with 100% sensitivity and 100% specificity. T

Alpha Pro Tech, Ltd. announced that the Company is set to join the broad-market Russell 3000® and Russell 2000® Indexes at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US equity market opens on June 29, 2020, according to a preliminary list of additions posted on June 5, 2020.

Today, the American Urological Association (AUA), in partnership with the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) released the 2020 clinical guideline for the diagnosis, evaluation and follow-up of microhematuria.

OpenText™ (NASDAQ: OTEX) (TSX: OTEX) today announced Rapid Radiology, one of the largest teleradiology providers in the U.S, has selected OpenText™ EMR-Link™ as its comprehensive solution for electronic medical record (EMR) integration and computerized physician order entry (CPOE).

Drawbridge Health today announced that the OneDraw™ Blood Collection Device, the enabling technology for the FDA cleared OneDraw™ A1C Test System, has won the prestigious Red Dot Award: Product Design 2020 in the category of Medical Devices

Data in pilot program with Mission Healthcare identified workforce-specific health and wellness issues, allowing the employer to create a customized initiative to improve staff wellbeing

In a head-to-head evaluation, significantly fewer silent brain infarcts were associated with CGuard™ EPS versus Acculink™ at 30 days post-procedure

Every year, approximately 10,000 people are rushed to the emergency department for fireworks injuries.

Abbott (NYSE: ABT) today announced late-breaking data on a number of its life-changing products to treat people with structural heart diseases.

Global Prior Art, the leading provider of patent research and analytics services, announced that Chris Smyth has joined GPA as Vice President, Business Development, effective June 1, 2020.